COMP <GO>
RFL vs VRCA // ENTERPRISE SCALE & MARKET CAP
Rafael Holdings Inc. (Class B) (NYSE) VS. Verrica Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: RFL 0
— VRCA 6
▲ ENTERPRISE SCALE & MARKET CAP LEADER: VRCA
LAST: $1.08 (-3.57%) • MKT CAP: $58.2M
market-cap
$58.2M
LAST: $3.35 (-2.05%) • MKT CAP: $58.8M
market-cap
$58.8M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RFL VS. VRCA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RFL | VRCA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -34.20% | -25.80 | VRCA | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -50.30% | -9.70 | VRCA | /net-margins <GO> |
| Revenue Growth (YoY) | -65.00% | 180.00% | -245.00 | VRCA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | VRCA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 31.0 | 34.1 | -3.10 | VRCA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $58.2M | $58.8M | -$511.5K | VRCA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RFL REV | VRCA REV | RFL GROSS % | VRCA GROSS % | RFL FCF | VRCA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $30.0K | $35.6M | — | — | -$18.9M | -$17.6M |
| FY 2024 | $637.0K | $7.6M | 75.8% | 65.6% | -$7.9M | -$61.0M |
| FY 2023 | $279.0K | $5.1M | — | — | -$10.9M | -$38.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RFL // BETA —
VRCA // BETA —